Jennifer Ker1, Tina V Hartert. 1. Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennesse 37232-8300, USA.
Abstract
OBJECTIVE: To review and compile data from published studies that provide support for the existence of the atopic march. DATA SOURCES: Relevant articles and references found via a PubMed search using the following keywords: atopic march, allergic march, atopic dermatitis, eczema, atopic eczema, atopy, rhinitis, wheeze, bronchiolitis, and asthma. STUDY SELECTION: All articles were reviewed and the most relevant were selected for inclusion in this review and for the compilation and graphical presentation of disease trends. RESULTS: Data on the prevalence of each phenotype of the atopic march confirm the temporal pattern of progression from eczema to allergic rhinitis and asthma. However, the atopic march as it is currently defined, is lacking precision, which affects its usefulness. Early events in the atopic march, such as eczema, may be more useful with more careful refinement of the phenotype into atopic and nonatopic eczema. CONCLUSION: Evidence supports that the atopic march is a useful paradigm to describe the clinically observed progression of atopy in certain children. There may be more precise phenotypes of the early stages of the atopic march that may improve its utility in predicting the development of later atopic, comorbid chronic disease.
OBJECTIVE: To review and compile data from published studies that provide support for the existence of the atopic march. DATA SOURCES: Relevant articles and references found via a PubMed search using the following keywords: atopic march, allergic march, atopic dermatitis, eczema, atopic eczema, atopy, rhinitis, wheeze, bronchiolitis, and asthma. STUDY SELECTION: All articles were reviewed and the most relevant were selected for inclusion in this review and for the compilation and graphical presentation of disease trends. RESULTS: Data on the prevalence of each phenotype of the atopic march confirm the temporal pattern of progression from eczema to allergic rhinitis and asthma. However, the atopic march as it is currently defined, is lacking precision, which affects its usefulness. Early events in the atopic march, such as eczema, may be more useful with more careful refinement of the phenotype into atopic and nonatopic eczema. CONCLUSION: Evidence supports that the atopic march is a useful paradigm to describe the clinically observed progression of atopy in certain children. There may be more precise phenotypes of the early stages of the atopic march that may improve its utility in predicting the development of later atopic, comorbid chronic disease.
Authors: Christian Möller; Sten Dreborg; Hosne A Ferdousi; Susanne Halken; Arne Høst; Lars Jacobsen; Antti Koivikko; Dieter Y Koller; Bodo Niggemann; Lene A Norberg; Radvan Urbanek; Erkka Valovirta; Ulrich Wahn Journal: J Allergy Clin Immunol Date: 2002-02 Impact factor: 10.793
Authors: Sarita Sehra; Florencia M Barbé Tuana; Mark Holbreich; Nico Mousdicas; Robert S Tepper; Cheong-Hee Chang; Jeffrey B Travers; Mark H Kaplan Journal: Crit Rev Immunol Date: 2008 Impact factor: 2.214
Authors: Anne Kotaniemi-Syrjänen; Raija Vainionpää; Tiina M Reijonen; Matti Waris; Kaj Korhonen; Matti Korppi Journal: J Allergy Clin Immunol Date: 2003-01 Impact factor: 10.793
Authors: Jennifer L St Sauver; David O Warner; Barbara P Yawn; Debra J Jacobson; Michaela E McGree; Joshua J Pankratz; L Joseph Melton; Véronique L Roger; Jon O Ebbert; Walter A Rocca Journal: Mayo Clin Proc Date: 2013-01 Impact factor: 7.616
Authors: Medina S Jackson-Browne; Melissa Eliot; Marisa Patti; Adam J Spanier; Joseph M Braun Journal: Int J Hyg Environ Health Date: 2020-05-30 Impact factor: 5.840